Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)Véronique Crutel, Bruno Falissard, Antoine Rosier et al.|Journal of Autism and Developmental Disorders|2020Cited by 38
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jannie van der Westhuizen, Jan K. Buitelaar et al.|The Lancet Psychiatry|2021Cited by 33